Top Key Companies for Non-invasive DNA Prenatal Testing Market: Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, Mutiplicon, Premaitha Health, Beijing BGI, Berry Genomics, Darui Biological.
Global Non-invasive DNA Prenatal Testing Market Size was estimated at USD 4765.9 million in 2022 and is projected to reach USD 10351.39 million by 2028, exhibiting a CAGR of 13.8% during the forecast period.
Global Non-invasive DNA Prenatal Testing Market Overview And Scope:
The Global Non-invasive DNA Prenatal Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Non-invasive DNA Prenatal Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Non-invasive DNA Prenatal Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive DNA Prenatal Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Non-invasive DNA Prenatal Testing market.
Global Non-invasive DNA Prenatal Testing Market Segmentation
By Type, Non-invasive DNA Prenatal Testing market has been segmented into:
Equipment
Consumables
By Application, Non-invasive DNA Prenatal Testing market has been segmented into:
Hospital
Clinic
Other
Regional Analysis of Non-invasive DNA Prenatal Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Non-invasive DNA Prenatal Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Non-invasive DNA Prenatal Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Non-invasive DNA Prenatal Testing market.
Top Key Companies Covered in Non-invasive DNA Prenatal Testing market are:
Illumina
Roche
Natera
Thermo Fisher Scientific
F. Hoffman-La Roche
Pacific Biosciences Of California
Perkinelmer
LifeCodexx
Agilent Technologies
Labcorp
Mutiplicon
Premaitha Health
Beijing BGI
Berry Genomics
Darui Biological
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Non-invasive DNA Prenatal Testing Market by Type
5.1 Non-invasive DNA Prenatal Testing Market Overview Snapshot and Growth Engine
5.2 Non-invasive DNA Prenatal Testing Market Overview
5.3 Equipment
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Equipment: Geographic Segmentation
5.4 Consumables
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Consumables: Geographic Segmentation
Chapter 6: Non-invasive DNA Prenatal Testing Market by Application
6.1 Non-invasive DNA Prenatal Testing Market Overview Snapshot and Growth Engine
6.2 Non-invasive DNA Prenatal Testing Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Non-invasive DNA Prenatal Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Non-invasive DNA Prenatal Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Non-invasive DNA Prenatal Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ILLUMINA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ROCHE
7.4 NATERA
7.5 THERMO FISHER SCIENTIFIC
7.6 F. HOFFMAN-LA ROCHE
7.7 PACIFIC BIOSCIENCES OF CALIFORNIA
7.8 PERKINELMER
7.9 LIFECODEXX
7.10 AGILENT TECHNOLOGIES
7.11 LABCORP
7.12 MUTIPLICON
7.13 PREMAITHA HEALTH
7.14 BEIJING BGI
7.15 BERRY GENOMICS
7.16 DARUI BIOLOGICAL
Chapter 8: Global Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Equipment
8.2.2 Consumables
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Other
Chapter 9: North America Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Equipment
9.4.2 Consumables
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Clinic
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Equipment
10.4.2 Consumables
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Clinic
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Equipment
11.4.2 Consumables
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Clinic
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Equipment
12.4.2 Consumables
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Clinic
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Equipment
13.4.2 Consumables
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Clinic
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Non-invasive DNA Prenatal Testing Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Equipment
14.4.2 Consumables
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Clinic
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Non-invasive DNA Prenatal Testing Scope:
|
Report Data
|
Non-invasive DNA Prenatal Testing Market
|
|
Non-invasive DNA Prenatal Testing Market Size in 2025
|
USD XX million
|
|
Non-invasive DNA Prenatal Testing CAGR 2025 - 2032
|
XX%
|
|
Non-invasive DNA Prenatal Testing Base Year
|
2024
|
|
Non-invasive DNA Prenatal Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx, Agilent Technologies, Labcorp, Mutiplicon, Premaitha Health, Beijing BGI, Berry Genomics, Darui Biological.
|
|
Key Segments
|
By Type
Equipment
Consumables
By Applications
Hospital
Clinic
Other
|
